Cooperation between China and Iran in addiction medicine: opportunities, challenges and strategies

IF 5.3 3区 医学 Q1 PSYCHIATRY General Psychiatry Pub Date : 2023-12-01 DOI:10.1136/gpsych-2023-101162
Gangliang Zhong, Hang Su, Di Zhao, Ji Hu, Xing Liu, Yonghui Li, Saeed Semnanian, Abbas Haghparast, Ti-Fei Yuan, Jiang Du
{"title":"Cooperation between China and Iran in addiction medicine: opportunities, challenges and strategies","authors":"Gangliang Zhong, Hang Su, Di Zhao, Ji Hu, Xing Liu, Yonghui Li, Saeed Semnanian, Abbas Haghparast, Ti-Fei Yuan, Jiang Du","doi":"10.1136/gpsych-2023-101162","DOIUrl":null,"url":null,"abstract":"Addiction is a major global risk factor for disability and premature death1 and has become a public health and social problem worldwide. Despite substantial investments from governments and research institutions globally, current addiction medicine research remains centred in Western countries. However, theories, models and results from western-centric research may not be applicable to different cultures. Non-Western countries such as China and Iran, and Western countries are committed to establishing addiction prevention and treatment tailored to their unique histories and cultures. To foster a global addiction science, it is important to increase the diversity of evidence without preconceived biases. Studying addiction problems across different regions and cultural backgrounds and sharing successful prevention and treatment models can provide a more comprehensive perspective for global addiction science, potentially yielding innovative solutions that benefit all countries. China and Iran have their own unique addiction challenges and treatment experiences and have become important representatives of addiction research progress in countries outside the Western axis. Both China and Iran have rich traditional medicine experiences in addiction medicine, which have been developed over thousands of years of trial and error. These offer valuable insights for refining addiction treatment and preventing relapse. Traditional Chinese medicine has a history of over 2000 years in China and has been used to treat addiction, including substance and non-substance addiction, for the past two centuries. Traditional herbal therapy, which targets multiple systems and mechanisms, is considered effective in relieving withdrawal symptoms and preventing addiction relapse with minimal side effects.2 3 It also has a rehabilitative effect on physical issues caused by long-term drug use, including improvements in immune function and working memory and the prevention of neurological diseases.4 The continuous application of traditional medical therapies in China and Iran has preliminarily proven effective in addiction treatment in Western countries, …","PeriodicalId":12549,"journal":{"name":"General Psychiatry","volume":null,"pages":null},"PeriodicalIF":5.3000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"General Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gpsych-2023-101162","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Addiction is a major global risk factor for disability and premature death1 and has become a public health and social problem worldwide. Despite substantial investments from governments and research institutions globally, current addiction medicine research remains centred in Western countries. However, theories, models and results from western-centric research may not be applicable to different cultures. Non-Western countries such as China and Iran, and Western countries are committed to establishing addiction prevention and treatment tailored to their unique histories and cultures. To foster a global addiction science, it is important to increase the diversity of evidence without preconceived biases. Studying addiction problems across different regions and cultural backgrounds and sharing successful prevention and treatment models can provide a more comprehensive perspective for global addiction science, potentially yielding innovative solutions that benefit all countries. China and Iran have their own unique addiction challenges and treatment experiences and have become important representatives of addiction research progress in countries outside the Western axis. Both China and Iran have rich traditional medicine experiences in addiction medicine, which have been developed over thousands of years of trial and error. These offer valuable insights for refining addiction treatment and preventing relapse. Traditional Chinese medicine has a history of over 2000 years in China and has been used to treat addiction, including substance and non-substance addiction, for the past two centuries. Traditional herbal therapy, which targets multiple systems and mechanisms, is considered effective in relieving withdrawal symptoms and preventing addiction relapse with minimal side effects.2 3 It also has a rehabilitative effect on physical issues caused by long-term drug use, including improvements in immune function and working memory and the prevention of neurological diseases.4 The continuous application of traditional medical therapies in China and Iran has preliminarily proven effective in addiction treatment in Western countries, …
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国与伊朗在成瘾医学领域的合作:机遇、挑战与战略
成瘾是导致残疾和过早死亡的一个主要全球性风险因素1 ,已成为一个全球性的公共卫生和社会问题。尽管全球各国政府和研究机构投入了大量资金,但目前的成瘾医学研究仍以西方国家为中心。然而,以西方为中心的研究理论、模式和结果可能并不适用于不同的文化。中国、伊朗等非西方国家和西方国家都致力于建立适合其独特历史和文化的成瘾预防和治疗体系。为了促进全球成瘾科学的发展,必须在不带先入为主偏见的情况下增加证据的多样性。研究不同地区和文化背景下的成瘾问题,分享成功的预防和治疗模式,可以为全球成瘾科学提供更全面的视角,并有可能产生惠及所有国家的创新解决方案。中国和伊朗有着各自独特的成瘾挑战和治疗经验,已成为西方轴心以外国家成瘾研究进展的重要代表。中国和伊朗在戒毒医学方面都有着丰富的传统医学经验,这些经验都是经过数千年的反复试验而形成的。这些经验为完善戒毒治疗和预防复吸提供了宝贵的启示。传统中医药在中国已有 2000 多年的历史,在过去的两个世纪中一直被用于治疗成瘾,包括药物成瘾和非药物成瘾。传统中草药疗法针对多个系统和机制,被认为能有效缓解戒断症状,防止毒瘾复发,且副作用极小。2 3 对长期吸毒引起的身体问题也有康复作用,包括改善免疫功能和工作记忆,预防神经系统疾病。4 中国和伊朗传统医学疗法的持续应用已初步证明对西方国家的毒瘾治疗有效, ...
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
General Psychiatry
General Psychiatry 医学-精神病学
CiteScore
21.90
自引率
2.50%
发文量
848
期刊介绍: General Psychiatry (GPSYCH), an open-access journal established in 1959, has been a pioneer in disseminating leading psychiatry research. Addressing a global audience of psychiatrists and mental health professionals, the journal covers diverse topics and publishes original research, systematic reviews, meta-analyses, forums on topical issues, case reports, research methods in psychiatry, and a distinctive section on 'Biostatistics in Psychiatry'. The scope includes original articles on basic research, clinical research, community-based studies, and ecological studies, encompassing a broad spectrum of psychiatric interests.
期刊最新文献
Desipramine reverses remote memory deficits by activating calmodulin-CaMKII pathway in a UTX knockout mouse model of Kabuki syndrome. Depressive symptomatology, NT-proBNP levels and health status in patients with heart failure: a prospective observational study. Neuroimaging studies in major depressive disorder with suicidal ideation or behaviour among Chinese patients: implications for neural mechanisms and imaging signatures. The sex-specific associations between suicidality and post-traumatic stress disorder in patients with physical injuries. Diminished functional segregation and resilience are associated with symptomatic severity and cognitive impairments in schizophrenia: a large-scale study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1